US Stock MarketDetailed Quotes

CERO CERo Therapeutics

Watchlist
  • 0.146
  • +0.000+0.07%
Trading Aug 19 09:55 ET
7.41MMarket Cap-39P/E (TTM)

CERo Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-2.07M
62.14%-1.44M
-16.00%-11.71M
-3.79M
-10.09M
Net income from continuing operations
---2.09M
30.64%-2.44M
-11.28%-11.83M
---3.52M
---10.63M
Operating gains losses
---261.82K
339.17%36.66K
96.23%-36.99K
---15.33K
---980.31K
Depreciation and amortization
--277.45K
8.81%273.58K
45.87%1.07M
--251.43K
--735.47K
Change In working capital
---35.5K
203.94%663.27K
-363.45%-1.3M
---638.13K
--492.34K
-Change in prepaid assets
---75.14K
167.91%90.1K
-49.26%49.59K
---132.68K
--97.73K
-Change in payables and accrued expense
--203.37K
299.99%733.03K
-210.47%-761.42K
---366.53K
--689.26K
-Change in other current liabilities
---163.73K
-15.07%-159.86K
-98.63%-585.25K
---138.92K
---294.65K
Cash from discontinued investing activities
Operating cash flow
---2.07M
62.14%-1.44M
-16.00%-11.71M
---3.79M
---10.09M
Investing cash flow
Cash flow from continuing investing activities
-13.33%-694.23K
-409.98K
-612.57K
Net PPE purchase and sale
----
----
-13.33%-694.23K
---409.98K
---612.57K
Cash from discontinued investing activities
Investing cash flow
----
----
-13.33%-694.23K
---409.98K
---612.57K
Financing cash flow
Cash flow from continuing financing activities
566.51K
5.17K
-90.66%5.63K
0
60.26K
Net issuance payments of debt
--605.23K
--0
----
----
----
Net preferred stock issuance
--0
--0
----
----
----
Proceeds from stock option exercised by employees
--600
--5.17K
-90.66%5.63K
--0
--60.26K
Cash from discontinued financing activities
Financing cash flow
--566.51K
--5.17K
-90.66%5.63K
--0
--60.26K
Net cash flow
Beginning cash position
--5.39M
-64.51%6.82M
-35.65%19.22M
--19.22M
--29.86M
Current changes in cash
---1.51M
65.95%-1.43M
-16.45%-12.4M
---4.2M
---10.65M
End cash Position
--3.88M
-64.11%5.39M
-64.51%6.82M
--15.01M
--19.22M
Free cash flow
---2.07M
65.83%-1.44M
-15.85%-12.4M
---4.2M
---10.71M
Currency Unit
USD
USD
USD
USD
USD
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -2.07M62.14%-1.44M-16.00%-11.71M-3.79M-10.09M
Net income from continuing operations ---2.09M30.64%-2.44M-11.28%-11.83M---3.52M---10.63M
Operating gains losses ---261.82K339.17%36.66K96.23%-36.99K---15.33K---980.31K
Depreciation and amortization --277.45K8.81%273.58K45.87%1.07M--251.43K--735.47K
Change In working capital ---35.5K203.94%663.27K-363.45%-1.3M---638.13K--492.34K
-Change in prepaid assets ---75.14K167.91%90.1K-49.26%49.59K---132.68K--97.73K
-Change in payables and accrued expense --203.37K299.99%733.03K-210.47%-761.42K---366.53K--689.26K
-Change in other current liabilities ---163.73K-15.07%-159.86K-98.63%-585.25K---138.92K---294.65K
Cash from discontinued investing activities
Operating cash flow ---2.07M62.14%-1.44M-16.00%-11.71M---3.79M---10.09M
Investing cash flow
Cash flow from continuing investing activities -13.33%-694.23K-409.98K-612.57K
Net PPE purchase and sale ---------13.33%-694.23K---409.98K---612.57K
Cash from discontinued investing activities
Investing cash flow ---------13.33%-694.23K---409.98K---612.57K
Financing cash flow
Cash flow from continuing financing activities 566.51K5.17K-90.66%5.63K060.26K
Net issuance payments of debt --605.23K--0------------
Net preferred stock issuance --0--0------------
Proceeds from stock option exercised by employees --600--5.17K-90.66%5.63K--0--60.26K
Cash from discontinued financing activities
Financing cash flow --566.51K--5.17K-90.66%5.63K--0--60.26K
Net cash flow
Beginning cash position --5.39M-64.51%6.82M-35.65%19.22M--19.22M--29.86M
Current changes in cash ---1.51M65.95%-1.43M-16.45%-12.4M---4.2M---10.65M
End cash Position --3.88M-64.11%5.39M-64.51%6.82M--15.01M--19.22M
Free cash flow ---2.07M65.83%-1.44M-15.85%-12.4M---4.2M---10.71M
Currency Unit USDUSDUSDUSDUSD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg